Wednesday, July 22, 2020

P55 - Characterization of in vivo disposition of CTI-1601: A mitochondria targeted therapy for friedreich’s ataxia

Eric Gonzalez, Erik Wagner, Nicholas Mess, Amy Wang, Mark Payne, David Bettoun, Elizabeth Ottinger, Bonnie Rup, Xin Xu, Drug Metabolism and Pharmacokinetics, Volume 35, Issue 1, Supplement, 2020, Page S38, doi:10.1016/j.dmpk.2020.04.056.


P55 - Characterization of in vivo disposition of CTI-1601: A mitochondria targeted therapy for friedreich’s ataxia